The European Union has made a deal to pay less for Pfizer’s COVID-19 vaccine candidate than the United States as they had secured an agreement for up to 300 million doses. This article is archived. Subscribe or log in to the Daily Newsbrief and gain access. Premium Access Unlimited access is just $1 /week You can cancel anytime. Unlimited articles with no ads Access with any of your devices Access to archived articles The Daily News Brief newsletter Special offers Early access to new features SUBSCRIBE NOW Not ready for a subscription? Simply sign up here (no credit card required) to get 5 free articles each month.